Targeting Neuroinflammation and Repair: The Rationale Behind Ibudilast | NeurologyLive

Treatment for amyotrophic lateral sclerosis (ALS) has historically been limited, with only a handful of therapies approved to modestly slow progression or manage symptoms. In recent years, however, clinical trial designs have become more…